Skip to main content

Beyond Medicine

Category: AI in Healthcare

A specialized digital therapeutics (DTx) company developing 'Clickless', an AI-powered software-based medical device designed to treat temporomandibular joint (TMJ) disorders through cognitive behavioral therapy and guided physical exercises. Beyond Medicine was founded in 2022. The company is led by Daehyun Kim. Based in Seoul, South Korea. Team size: 11-50. Total funding raised: $1.6M. Latest round: Pre-Series A. Key investors include TA Advisors, Digital Healthcare Partners (DHP), Infobank, Bigbang Angels, Yoonmin Creative Investment Foundation, Korea Credit Guarantee Fund, Samsung Fire & Marine Insurance.

Founded
2022
Headquarters
Seoul, South Korea
Team size
11-50
Total funding
$1.6M

Value proposition

Provides a non-invasive, accessible, and clinically validated alternative to traditional TMJ treatments, reducing pain by over 3x through AI-monitored habit correction and personalized rehabilitation.

Products and solutions

Clickless DTx (Digital Therapeutic for TMJ), AI Posture & Jaw Movement Analysis Engine, TMD Patient Habit Tracking & Feedback System, Clinical Dashboard for Dental Practitioners

Unique value

Developed the first digital therapeutic specifically for the dental sector in South Korea, addressing a specialized medical niche (TMJ) that previously lacked standardized digital intervention.

Target customer

Patients suffering from temporomandibular disorders (TMD), dental clinics, military healthcare systems, and global dental distribution networks.

Industries served

Digital Therapeutics (DTx), Dentistry, Healthcare AI, Telemedicine

Technology advantage

Leverages AI-based vision technology for real-time posture analysis and exercise monitoring, combined with a 96% clinical success rate validated through trials at Hallym University Hospital and publication in the JMIR journal.

How they differentiate

Beyond Medicine is the world's first to offer a certified digital therapeutic (DTx) specifically for Temporomandibular Joint (TMJ) disorders. Unlike general musculoskeletal (MSK) platforms that focus on back or joint pain, 'Clickless' uses specialized AI vision for jaw movement analysis and Cognitive Behavioral Therapy (CBT) tailored to dental patients.

Main competitors

Hinge Health, Sword Health, Kaia Health

Key partnerships

Hallym University Hospital (Clinical Trial Partner), Glidewell (US Dental Distribution Partner), Carequest (US Strategic Partner), Ministry of Food and Drug Safety (Innovative Medical Device Designation #82), Yoonmin Creative Investment Foundation (Investor), Korea Credit Guarantee Fund (Investor), Samsung Fire & Marine Insurance InfoBank (Investor)

Notable customers

Hallym University Sacred Heart Hospital, Republic of Korea Armed Forces (Military Doctors), Glidewell (US Partner), Carequest (US Partner), 80+ dental clinics/hospitals committed to prescribing Clickless (SIDEX 2026)

Major milestones

Won the Grand Prize (Presidential Award) at 'Challenge! K-Startup 2022', Secured Pre-Series A funding from TA Advisors in Feb 2024, Designated as the 82nd Innovative Medical Device by the MFDS in May 2025, Received Investment from Digital Healthcare Partners (DHP) in July 2025, Obtained MFDS Class 2 Medical Device Approval for 'Clickless' in Dec 2025, Participated in CES 2026 Unveiled for global market entry, Won Grand Prize at 2nd Shin Kyuk-ho Lotte Young Entrepreneur Awards (Jan 2026), Participated in KIMES 2026 showcasing Clickless (Mar 2026), SIDEX 2026: 80+ dental clinics expressed intent to prescribe Clickless (May 2026), Domestic prescriptions starting June 2026

Growth metrics

Achieved a 96% success rate in clinical trials at Hallym University; research published in the Journal of Medical Internet Research (JMIR) with 90%+ patient pain reduction.

Market positioning

Pioneer in the Dental Digital Therapeutics (DTx) niche

Geographic focus

South Korea, North America (USA), Europe

Patents and IP

1 registered patent and 13 trademarks related to TMJ digital treatment and the 'Clickless' brand as of early 2025.

About Daehyun Kim

Daehyun Kim is a dentist-turned-entrepreneur who founded Beyond Medicine in 2022. He served as a military doctor in the Republic of Korea Armed Forces, where he first conceptualized digital therapeutics for dental care. He gained national recognition by winning the Grand Prize (Presidential Award) in the 'Challenge! K-Startup 2022' Defense League. He is a specialist in digital therapeutics (DTx) for temporomandibular joint (TMJ) disorders.

Official website: